. 2011 Jul 15;6(7):e21877. doi: 10.1371/journal.pone.0021877

Table 2. Loss of p19^arf cooperates with v-ras^Ha in malignant conversion.

	Normal Skin	Papilloma	Carcinoma	Total	Conversion rate
Lenti-GFP/v-ras^Ha	0	5	0	5	0%
Lenti-ΔNp63α/v-ras^Ha	0	0	5	5	100%
p19^arf null/v-ras^Ha	0	1	9	10	90%
p19^arf null/Lenti-ΔNp63α/v-ras^Ha	0	0	10	10	100%

Tumor incidence and conversion rate of grafted p19^arf null keratinocytes are presented at 5 weeks post-grafting. Tumor phenotypes were confirmed histologically.

Table 2. Loss of p19arf cooperates with v-rasHa in malignant conversion.

Table 2. Loss of p19^arf cooperates with v-ras^Ha in malignant conversion.